Published in Am J Hypertens on June 01, 1990
Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat. Br J Pharmacol (1992) 0.92
Effect of alpha-human atrial natriuretic peptide on the synthesis of dopamine in the rat kidney. Br J Pharmacol (1992) 0.81
Statins do more than just lower cholesterol. Lancet (1996) 4.39
Management of hyperglycemic crises in patients with diabetes. Diabetes Care (2001) 4.04
Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med (1983) 3.27
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem (2001) 2.02
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology (1997) 1.87
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med (1986) 1.53
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain (2008) 1.19
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry (2002) 1.16
The dual-specificity CLK kinase induces neuronal differentiation of PC12 cells. Mol Cell Biol (1994) 1.15
Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med (1993) 1.12
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol (1982) 1.10
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
Mapping of the novel protein kinase catalytic domain of Dictyostelium myosin II heavy chain kinase A. J Biol Chem (1997) 1.08
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci (2007) 1.00
Iridectomy in primary angle-closure glaucoma. Classification and differential diagnosis of glaucoma associated with narrowness of the angle. Arch Ophthalmol (1974) 0.99
Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks. Am J Hypertens (1992) 0.97
Effects of intravenous infusions of prostaglandin D2 in man. Prostaglandins (1984) 0.96
Physical activity level is an independent predictor of the diurnal variation in blood pressure. J Hypertens (2000) 0.96
Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine. Clin Pharmacol Ther (1983) 0.93
Ambulatory blood pressure monitoring: which arm? J Hum Hypertens (2000) 0.93
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans. Clin Pharmacol Ther (1991) 0.91
Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol (1999) 0.89
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients. Circulation (1995) 0.88
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environ Int (2011) 0.88
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol (1988) 0.88
Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping? Am J Hypertens (2000) 0.88
Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure. J Cardiovasc Pharmacol (1984) 0.87
The influence of physical activity on the variability of ambulatory blood pressure. Am J Hypertens (2000) 0.87
Ethnic differences in circadian hemodynamic profile. Am J Hypertens (1994) 0.86
Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J Pharmacol Exp Ther (1987) 0.86
Nifedipine and alpha adrenoceptor antagonism. Clin Pharmacol Ther (1984) 0.86
Identification and characterization of a nerve growth factor-stimulated mitogen-activated protein kinase activator in PC12 cells. J Biol Chem (1993) 0.85
Diurnal blood pressure variability and physical activity measured electronically and by diary. Am J Hypertens (1993) 0.84
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol (1991) 0.83
5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle. J Pharmacol Exp Ther (1992) 0.83
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia (2008) 0.82
The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin. Eur J Clin Pharmacol (1985) 0.82
Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus. Hypertension (1986) 0.81
Potential use of DA1 and DA2 receptor agonists in the treatment of hypertension. Clin Exp Hypertens A (1987) 0.80
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation (1990) 0.80
Effects of selective dopamine-1 receptor activation on intraocular pressure in man. Exp Eye Res (1988) 0.80
Dopamine receptor agonists in cardiovascular medicine. Trends Cardiovasc Med (1991) 0.80
Dementia and statins. PROSPER study group. Lancet (2001) 0.80
Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. Am J Med (1988) 0.79
IgG sub-class levels in healthy Irish adults--a population study. Ir J Med Sci (1981) 0.79
Evidence for a peripheral component in the sympatholytic actions of clonidine and guanfacine in man. Eur J Clin Pharmacol (1984) 0.79
Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycemic, hyperosmolar nonketotic coma (HHNC). Diabetes Care (1984) 0.78
Isolated systolic hypertension in the elderly. JAMA (1991) 0.78
Benign mixed tumor of the (palpebral) lacrimal gland presenting as a nodular eyelid lesion. Am J Ophthalmol (1974) 0.78
Efficacy of nifedipine as a step 3 antihypertensive drug. Hypertension (1983) 0.78
Polycyclic musks in green-lipped mussels (Perna viridis) from Hong Kong. Mar Pollut Bull (2008) 0.77
Effects of dopamine receptor activation on the level of cyclic AMP in the trabecular meshwork. Invest Ophthalmol Vis Sci (1989) 0.77
Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism. J Cardiovasc Pharmacol (1999) 0.77
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension. J Clin Pharmacol (1993) 0.77
Chest percussion: help or hindrance to postural drainage? Ir Med J (1983) 0.76
Treatment of spastic dystonia with transdermal nicotine. Lancet (1997) 0.76
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Exp Gerontol (2008) 0.76
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. Br Heart J (1984) 0.76
Left ventricular myxoma presenting with constitutional symptoms and raised serum interleukin-6 both suppressed by naproxen. Eur Heart J (1997) 0.76
Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney. J Pharmacol Exp Ther (1990) 0.76
The use of ambulatory blood pressure monitoring in the evaluation of racial differences in blood pressure. J Cardiovasc Risk (1994) 0.76
Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic. J Heart Lung Transplant (1991) 0.76
Dopamine receptors and intraocular pressure. Trends Pharmacol Sci (1988) 0.75
Does hyperthyroidism predispose to thioridazine-induced hyperpyrexia and cardiac arrhythmias? Postgrad Med J (1984) 0.75
Unstable angina pectoris. N Engl J Med (2000) 0.75
Supervised drug administration in patients with refractory hypertension unmasking noncompliance. Postgrad Med J (1997) 0.75
Theophylline and depression. Br Med J (1980) 0.75
Location of vascular alpha 2-adrenoceptors in man. Br J Clin Pharmacol (1984) 0.75
Hypotension and the pentolinium suppression test. Lancet (1983) 0.75
Evaluation of the Suntech Accutracker. A novel noninvasive ambulatory blood pressure monitor. Am J Hypertens (1988) 0.75
Influence of diuretic therapy on the clonidine suppression test. J Clin Pharmacol (1991) 0.75
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug. J Cardiovasc Pharmacol (1989) 0.75
Role of nifedipine in the treatment of resistant hypertension. Comparison with hydralazine in hospital outpatients. Am J Med (1984) 0.75
The diabetic patient who mistreated herself. Hosp Pract (Off Ed) (1982) 0.75
Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine. Am J Emerg Med (1990) 0.75
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Intern Med (1992) 0.75
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride. Am J Cardiol (1988) 0.75
Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans. Hypertension (1984) 0.75
Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man. Miner Electrolyte Metab (1988) 0.75
A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia (1997) 0.75
Factors confounding assessment of ambulatory blood pressure monitors, studied during formal evaluation of the Tycos Quiet-Trak. Am J Hypertens (1997) 0.75
Effect of hemolysis on radioenzymic assay of plasma catecholamines. Clin Chem (1982) 0.75
Diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic coma. Med Clin North Am (1988) 0.75
Therapeutic applications of drugs acting on peripheral dopamine receptors. J Clin Pharmacol (1990) 0.75
Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion. Clin Exp Hypertens A (1991) 0.75
Electronic activity-monitor-derived sleeping and awake times and diurnal variation of blood pressure. Blood Press Monit (2000) 0.75
Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma. Arch Intern Med (1989) 0.75
Treatment of hypertension with calcium antagonists. Int J Clin Pharmacol Res (1985) 0.75
Beta-blockade and mental performance. Arch Intern Med (1989) 0.75
Synthetic polycyclic musks in Hong Kong sewage sludge. Chemosphere (2008) 0.75
The effects of pentolinium on sympathetic activity in hypertensives and normotensive controls. Int J Clin Pharmacol Res (1983) 0.75
Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension. J Hum Hypertens (1993) 0.75
Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass. Ann Thorac Surg (1995) 0.75
Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor. J Hum Hypertens (1990) 0.75
New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy. Drugs (1990) 0.75
Peripheral dopamine receptors in cardiovascular therapy. The legacy of Leon Goldberg (1927-1989). Hypertension (1991) 0.75
Distribution of perfluorinated compounds in surface seawaters between Asia and Antarctica. Mar Pollut Bull (2007) 0.75